Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Kidney International

Volumn 85, Issue 1, 2014, Pages 23-30

  Morrish, Alicia T ^a   Hawley, Carmel M ^a,b   Johnson, David W ^a,b   Badve, Sunil V ^a,b   Perkovic, Vlado ^a,c   Reidlinger, Donna M ^a   Cass, Alan ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

chronic kidney disease; clinical trials; collaborative research; health policy; investigator initiated; randomized controlled trial

Indexed keywords

AUSTRALIA AND NEW ZEALAND; CAREER; CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; EDUCATION; EXPERIENCE; FUNDING; GOOD CLINICAL PRACTICE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; NEPHROLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; REVIEW; SCIENTIST;

AUSTRALASIA; HUMANS; NEPHROLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891557350     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.391     Document Type: Article

References (31)

1. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259. (Pubitemid 47172384)
2. White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660-670.
3. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003; 14(Suppl 2): S131-S138. (Pubitemid 36750508)
4. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)
5. Australian Government Budget - Budget Paper No. 1. Statement 6: Expenses and Net Capital Investment. Parkes, ACT: The Commonwealth of Australia 2011, pp 21-25.
6. Annual Data Report, Chapter 11. United States Renal Data System, 2011. Available at http://www.usrds.org/2011/pdf/v2-ch011-11.pdf (29 May 2012).
7. Annual Data Report, Chapter 12. United States Renal Data System. Available at http://www.usrds.org/2011/pdf/v2-ch012-11.pdf (29 May 2012).
8. National Health Insurance Annual Statistical Report 1995-2009. Taiwan: Bureau of National Health Insurance, 2011. Available at http://www.nhi. gov.tw/webdata/webdata.aspx?menu=17&menu-id=661&WD-ID=689& webdata-id=3351(29 May 2012).
9. Couser WG, Remuzzi G, Mendis S et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-1270.
10. Strippoli GF, Craig JC, Schena FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15: 411-419. (Pubitemid 38140782)
11. Palmer SC, Sciancalepore M, Strippoli GF. Trial quality in nephrology: how are we measuring up? Am J Kidney Dis 2011; 58: 335-337.
12. Deo A, Schmid CH, Earley A et al. Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis 2011; 58: 349-355.
13. Califf RM, Zarin DA, Kramer JM et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012; 307: 1838-1847.
14. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619.
15. Vincent JL. Logistics of large international trials: the good, the bad, and the ugly. Crit Care Med 2009; 37(Suppl): S75-S79.
16. Ad Hoc Committee on Nephrology Manpower Needs. Estimating workforce and training requirements for nephrologists through the year 2010. J Am Soc Nephrol 1997; 8(Suppl 5): S9-S13.
17. Lane CA, Brown MA. Nephrology: a specialty in need of resuscitation? Kidney Int 2009; 76: 594-596.
18. Samuels JA, Molony DA. Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence. Adv Chronic Kidney Dis 2012; 19: 40-46.
19. Easterbrook PJ, Matthews DR. Fate of research studies. Journal of the Royal Society of Medicine 1992; 85: 71-76.
20. Decullier E, Chapuis F. Impact of funding on biomedical research: a retrospective cohort study. BMC Public Health 2006; 6: 165.
21. Dickersin K, Min YI. Publication bias: the problem that won't go away. Ann NY Acad Sci 1993; 703: 135-146, discussion 46-48.
22. Irish A, Dogra G, Mori T et al. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. BMC Nephrol 2009; 10: 1.
23. Johnson DW, Clark C, Isbel NM et al. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-Associated infections in peritoneal dialysis patients. Periton Dial Int 2009; 29: 303-309.
24. Johnson DW, Hawley CM, Rosser B et al. Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial. BMC Nephrol 2008; 9: 8.
25. Badve SV, Hawley CM, Johnson DW. Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD? Nephrology 2011; 16: 144-153.
26. Badve SV, Brown F, Hawley CM et al. Challenges of conducting a trial of uric-Acid-lowering therapy in CKD. Nat Rev Nephrol 2011; 7: 295-300.
27. Badve SV, Roberts MA, Hawley CM et al. Effects of beta-Adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-Analysis. J Am Coll Cardiol 2011; 58: 1152-1161.
28. Navaneethan SD, Palmer SC, Smith A et al. How to design a randomized controlled trial. Nephrology 2010; 15: 732-739.
29. Smith A, Palmer S, Johnson DW et al. How to conduct a randomized trial. Nephrology 2010; 15: 740-746.
30. Badve SV, Smith A, Hawley CM et al. Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. Letter: NDT Plus 2011; 2: 508.
31. Thomas KS, Koller K, Foster K et al. The UK clinical research network - has it been a success for dermatology clinical trials? Trials 2011; 12: 153.